A recent study published in JAMA Health Forum has highlighted significant gaps in the tracking of opioid use among older adults receiving post-acute care under Medicare. This critical research, conducted by the Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research, brings to light the underreporting of opioid dispensing, particularly for patients admitted to skilled nursing facilities (SNFs) after hospitalization.

Overview of the Study

The research letter entitled "Opioid Exposure Measurement in Postacute Care Under Medicare Consolidated Payments" analyzed Medicare Part D claims in comparison to records from long-term care pharmacies servicing SNFs. The results indicated a significant discrepancy in opioid usage reporting that may affect pain management and health policy decisions.

Key Findings

Among the key findings of the study, the researchers analyzed data from 52,586 opioid-naive Medicare beneficiaries who were admitted to SNFs following a hip fracture. The following observations were made:

  • High Opioid Use: A staggering 71.4% of patients received an opioid within 100 days of their admission.
  • Discrepancies in Reporting: At 31 days post-admission, pharmacy data indicated that 86.5% of patients continued to receive opioids, whereas only 19.4% of these prescriptions were captured in Medicare Part D claims.
  • Undercounting of Opioid Prescriptions: Within 100 days of SNF admission, 65% of patients who received opioids were not accounted for in Medicare claims, raising concerns about the accuracy of current data sources.

Importance of Accurate Tracking

Correct tracking of opioids is paramount since older adults recovering from surgical procedures, fractures, or illnesses are particularly vulnerable while in post-acute care settings. This period represents a critical transition where patients may face medication errors, side effects, or potential opioid overuse. The implications of inaccurate data on opioid prescriptions could lead to:

  1. Misleading Policy Decisions: Underestimating opioid prescriptions may give healthcare policymakers a false sense of progress in addressing opioid use.
  2. Inadequate Patient Monitoring: Failure to capture comprehensive opioid usage data limits efforts to monitor patient safety and prevent dependency.
"Accurate data on medication use are essential to protecting patients," stated Dr. Sarah Berry, MD, MPH, senior scientist at the Hinda and Arthur Marcus Institute for Aging Research. "If we underestimate how often opioids are prescribed in skilled nursing facilities, we risk missing opportunities to monitor safety and efficacy, prevent dependency, and guide policy."

Suggestions for Improvement

The authors of the study advocate for the integration of data from long-term care pharmacies to enhance the measurement of medication use in post-acute care settings. Incorporating such data could significantly improve the accuracy of opioid-related research and inform health policy.

Conclusion

In summary, the discrepancies identified in opioid prescription data for older adults in skilled nursing facilities reveal important blind spots in our understanding of opioid exposure in this vulnerable population. Researchers emphasize that the inclusion of comprehensive pharmacy data is crucial for accurately tracking opioid usage, which can ultimately affect pain management strategies and health policy initiatives.

References

Corcoran, K. L., et al. (2025). Opioid Exposure Measurement in Postacute Care Under Medicare Consolidated Payments. JAMA Health Forum.

Retrieved from Medical Xpress.